Carole Federico, PhD, MSc completed an MSc in Bioethics, followed by a PhD in Experimental Medicine at McGill University. Her dissertation, supervised by Jonathan Kimmelman, applied meta-analytic techniques to understand inefficiencies in the clinical translation of pain drugs. Carole's research focuses on rigor and reproducibility in biomedical science, with a special interest in the conditions of ethical animal research and how preclinical findings affect uncertainty at the transition between preclinical and clinical testing. At Stanford her work is supported by the National Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program.
Ryan Felder, PhD is a bioethicist and philosopher. Prior to his appointment at Stanford Health Care, he completed a fellowship at Montefiore Einstein Medical Center in Bronx, NY. Ryan earned his Ph.D in Philosophy from The Graduate Center, City University of New York in September 2021. He has taught and assisted graduate-level bioethics courses at Icahn School of Medicine at Mount Sinai and New York University, and taught philosophy to undergraduates at Lehman College, City University of New York. Ryan's writing on applied ethics has appeared in journals such as Hastings Center Report and Journal of Applied Philosophy. Ryan's research interests include epistemic injustice in clinical ethics and communication, the ethics of artificial intelligence in health care, and the implications of contemporary pragmatism for normative ethics and metaethics. Ryan received his Bachelor's from Rutgers University and his Master's from Binghamton University, both in philosophy. In his spare time, he enjoys taking long walks around the neighborhood, cooking, and art house films in small movie theaters.
Brandy M. Fox, PhD, is a Research Fellow at the Stanford Center for Biomedical Ethics with support from a National Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program training grant. She received her Ph.D. in Health Care Ethics with a concentration in Empirical Research from The Albert Gnaegi Center for Health Care Ethics at Saint Louis University under the supervision of Harold Braswell. She also holds a BA in Politics from The Catholic University of America and an MS in Health Care Ethics from Creighton University. Brandy served as an officer in the US Army and has worked for the Department of Veterans Affairs and Creighton University School of Pharmacy and Health Professions. Brandy is interested in the impact of genetic research on mental health diagnoses and treatment, including how mental illness is defined and conceptualized. Her work has appeared in a variety of academic journals, including HealthCare Ethics Committee Forum and Journal of Veterans Studies.
Kevin Mintz, PhD, received his Ph.D. from the Department of Political Science here at Stanford University in 2019 under the supervision of Debra Satz. He also holds an AB in Government from Harvard College, an MSc in Political Theory from the London School of Economics and Political Science, and a Doctorate of Human Sexuality from the Institute for Advanced Study of Human Sexuality. Prior to returning to Stanford, Kevin was a Postdoctoral Fellow in The Department of Bioethics at the National Institutes of Health. His research focuses on disability bioethics, research ethics, business ethics, and the degree to which genetics should be used to construct social or political identities. His work has appeared in a variety of academic journals and newspapers, including Pediatrics, The Hastings Center Report, and the Los Angeles Times.
Artem Trotsyuk, PhD received his Ph.D. in Biomedical Engineering from Stanford University in 2022 and a Master’s in Computer Science, AI Specialization Track, in 2021. His BS is in Biological Sciences, with an emphasis in Neurology, Physiology, and Behavior, from UC Davis. In 2020, he was a McCoy Family Center for Ethics in Society Fellow, and in 2019 an Enhancing Diversity in Graduate Education (EDGE) Fellow. In 2019 he was named a Forbes 30 under 30 Scholar. He has experience in venture capital and consulting in biotechnology and health policy. Some of his recent work includes outlining risks associated with data misuse and developing frameworks for the ethical use of patient data.